Zydus Lifesciences
Zydus Lifesciences Q4 consolidated net profit dips 25.36% to Rs 296.6 cr
Zydus Lifesciences gets USFDA nod to sell its cancer medicine in American market
Zydus Lifesciences gets USFDA final approval to market diabetes drug